{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:19:36Z","timestamp":1789697976268,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008666","name":"Marathon Foundation of Tv3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PDC2022\\u2013133858-I00"],"award-info":[{"award-number":["PDC2022\\u2013133858-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005053","name":"Biomedical Research Network Centre of Bioengineering Biomaterials and Nanomedicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00012"],"award-info":[{"award-number":["PI24\/00012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00400"],"award-info":[{"award-number":["PI20\/00400"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01621"],"award-info":[{"award-number":["PI20\/01621"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00318"],"award-info":[{"award-number":["PI23\/00318"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00150"],"award-info":[{"award-number":["PI21\/00150"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00013"],"award-info":[{"award-number":["PI24\/00013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/01476"],"award-info":[{"award-number":["PI24\/01476"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d&apos;Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020618","name":"Josep Carreras Leukaemia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21135"],"award-info":[{"award-number":["CA21135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118573","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:41:14Z","timestamp":1758699674000},"page":"118573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-9306","authenticated-orcid":false,"given":"Annabel","family":"Garcia-Le\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n I.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Alba-Castellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep F.","family":"Nomded\u00e9u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-0424","authenticated-orcid":false,"given":"Esther","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2615-4521","authenticated-orcid":false,"given":"Antonio","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Mangues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugutz","family":"Unzueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isolda","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118573_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118573_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5045\/br.2020.S001","article-title":"Classification of acute myeloid leukemia","volume":"55","author":"Hwang","year":"2020","journal-title":"Blood Res."},{"key":"10.1016\/j.biopha.2025.118573_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2025.118573_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fgene.2020.00480","article-title":"Treatment of acute myeloid leukemia in the era of Genomics-Achievements and persisting challenges","volume":"11","author":"Green","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.biopha.2025.118573_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118573_bib6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118573_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118573_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118573_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2022.280800","article-title":"Leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118573_bib10","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s12015-022-10349-5","article-title":"Leukemic stem cell signatures in acute myeloid leukemia- targeting the guardians with novel approaches","volume":"18","author":"Thakral","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2025.118573_bib11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2016-02-695312","article-title":"Evolution of acute myelogenous leukemia stem cell properties after treatment and progression","volume":"128","author":"Ho","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118573_bib12","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","article-title":"High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival","volume":"11","author":"van Rhenen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118573_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4252\/wjsc.v11.i8.476","article-title":"Bone marrow microenvironment: The Guardian of leukemia stem cells","volume":"11","author":"Houshmand","year":"2019","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.biopha.2025.118573_bib14","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/0008-5472.CAN-03-3693","article-title":"CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD\/SCID mice","volume":"64","author":"Tavor","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118573_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/cdd.2014.89","article-title":"Regulation of hematopoietic and leukemic stem cells by the immune system","volume":"22","author":"Riether","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118573_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2010.31.0904","article-title":"Leukemia stem cells and microenvironment: biology and therapeutic targeting","volume":"29","author":"Konopleva","year":"2011","journal-title":"JCO"},{"key":"10.1016\/j.biopha.2025.118573_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bjh.16456","article-title":"Dissecting the role of the CXCL12\/CXCR4 axis in acute myeloid leukaemia","volume":"189","author":"Ladikou","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118573_bib18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118573_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.22510","article-title":"Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype","volume":"109","author":"Konoplev","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2025.118573_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","article-title":"Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia","volume":"104","author":"Rombouts","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118573_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13076","article-title":"Role of CXCR4 in the progression and therapy of acute leukaemia","volume":"54","author":"Su","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2025.118573_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2141.2000.02157.x","article-title":"Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia","volume":"110","author":"M\u00f6hle","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118573_bib23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/1541-7786.MCR-13-0114","article-title":"Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML","volume":"11","author":"Sison","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118573_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107684","article-title":"CXCR4 signaling has a CXCL12-Independent essential role in murine MLL-AF9-Driven acute myeloid leukemia","volume":"31","author":"Ramakrishnan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118573_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","article-title":"The significance of cancer cell expression of the chemokine receptor CXCR4","volume":"14","author":"Balkwill","year":"2004","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2025.118573_bib26","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ijc.22024","article-title":"Chemokines and cancer","volume":"119","author":"Zlotnik","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118573_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118573_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00607","article-title":"Leukemia stem cell release from the stem cell niche to treat acute myeloid leukemia","volume":"8","author":"Villatoro","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118573_bib29","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3389\/fonc.2020.01672","article-title":"Targeting CXCR4 in AML and ALL","volume":"10","author":"Cancilla","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118573_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-020-00863-9","article-title":"An auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination","volume":"13","author":"Pallar\u00e8s","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118573_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3324\/haematol.2018.211490","article-title":"A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models","volume":"105","author":"Falg\u00e0s","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118573_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bcp.13126","article-title":"Microtubule destabilising agents: far more than just antimitotic anticancer drugs","volume":"83","author":"Bates","year":"2017","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118573_bib33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2147\/IJN.S289733","article-title":"Specific cytotoxic effect of an auristatin nanoconjugate towards CXCR4+ diffuse large B-Cell lymphoma cells","volume":"16","author":"Falg\u00e0s","year":"2021","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118573_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12015-016-9670-8","article-title":"Cellular GFP toxicity and immunogenicity: potential confounders in in vivo cell tracking experiments","volume":"12","author":"Ansari","year":"2016","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2025.118573_bib35","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.gt.3301335","article-title":"Immunogenicity of enhanced Green fluorescent protein (EGFP) in BALB\/c mice: identification of an H2-Kd-restricted CTL epitope","volume":"7","author":"Gambotto","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2025.118573_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/gt.2008.177","article-title":"Identification of the murine firefly luciferase-specific CD8 T-cell epitopes","volume":"16","author":"Limberis","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2025.118573_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2022.01.017","article-title":"Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery","volume":"343","author":"Serna","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118573_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.actbio.2021.06.001","article-title":"Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines","volume":"130","author":"\u00c1lamo","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.118573_bib39","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1535-7163.MCT-16-0408","article-title":"Mechanisms of resistance to Antibody\u2013Drug conjugates","volume":"15","author":"Loganzo","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118573_bib40","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1039\/C8CS00676H","article-title":"Cleavable linkers in antibody\u2013drug conjugates","volume":"48","author":"Bargh","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.118573_bib41","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1007\/s40843-023-2571-6","article-title":"Site-directed cysteine coupling of disulfide-containing non-antibody carrier proteins (THIOCAPs)","volume":"66","author":"Rueda","year":"2023","journal-title":"Sci. China Mater."},{"key":"10.1016\/j.biopha.2025.118573_bib42","first-page":"4533","article-title":"Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles","author":"Unzueta","year":"2012","journal-title":"Int. J. Nanomed. 7"},{"key":"10.1016\/j.biopha.2025.118573_bib43","unstructured":"Biofabrication of functional protein nanoparticles through simple His-tag engineering |, ACS\u00a0Sustain.\u00a0Chem.\u00a0Eng. https:\/\/pubs.acs.org\/doi\/10.1021\/acssuschemeng.1c04256."},{"key":"10.1016\/j.biopha.2025.118573_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13062-021-00313-7","article-title":"A link between mitotic defects and mitotic catastrophe: detection and cell fate","volume":"16","author":"Sazonova","year":"2021","journal-title":"Biol. Direct"},{"key":"10.1016\/j.biopha.2025.118573_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708772","article-title":"Selective depletion of metastatic stem cells as therapy for human colorectal cancer","volume":"10","author":"C\u00e9spedes","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2025.118573_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2016.12.020","article-title":"A randomized phase II study of LY2510924 and carboplatin\/etoposide versus carboplatin\/etoposide in extensive-disease small cell lung cancer","volume":"105","author":"Salgia","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2025.118573_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/08820139.2018.1497057","article-title":"Enhanced Anti-Leukemic effects through induction of immunomodulating microenvironment by blocking CXCR4 and PD-L1 in an AML mouse model","volume":"48","author":"Hwang","year":"2019","journal-title":"Immunol. Invest"},{"key":"10.1016\/j.biopha.2025.118573_bib48","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118573_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2022.280800","article-title":"Leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118573_bib50","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2008-06-161539","article-title":"CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure","volume":"113","author":"Fiegl","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118573_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/cancers15030713","article-title":"Mechanisms of ADC toxicity and strategies to increase ADC tolerability","volume":"15","author":"Nguyen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118573_bib52","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/14740338.2023.2277801","article-title":"A pharmacovigilance study on drug-induced liver injury associated with antibody-drug conjugates (ADCs) based on the food and drug administration adverse event reporting system","volume":"23","author":"Sun","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.biopha.2025.118573_bib53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1158\/0008-5472.CAN-17-1638","article-title":"Improved tumor penetration and Single-Cell targeting of antibody drug conjugates increases anticancer efficacy and host survival","volume":"78","author":"Cilliers","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118573_bib54","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/acs.molpharmaceut.5b00302","article-title":"Antibody-Drug conjugates (ADCs): magic bullets at last!","volume":"12","author":"Lambert","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118573_bib55","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/s41375-024-02326-3","article-title":"CXCR4 as a therapeutic target in acute myeloid leukemia","volume":"38","author":"Korbecki","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118573_bib56","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00277-015-2442-8","article-title":"VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia","volume":"94","author":"Bae","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.biopha.2025.118573_bib57","article-title":"Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia","volume":"98","author":"Cao","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2025.118573_bib58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/1535-7163.MCT-23-0118","article-title":"Brentuximab Vedotin\u2013Driven microtubule disruption results in endoplasmic reticulum stress leading to immunogenic cell death and antitumor immunity","volume":"23","author":"Heiser","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118573_bib59","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118573_bib60","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"Wilkins","year":"1999","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118573_bib61","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2025.118573_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2105-15-82","article-title":"Transient protein-protein interface prediction: datasets, features, algorithms, and the RAD-T predictor","volume":"15","author":"Bendell","year":"2014","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biopha.2025.118573_bib63","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","article-title":"Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate","volume":"10","author":"Hamblett","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118573_bib64","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/pharmaceutics15030727","article-title":"T22-PE24-H6 nanotoxin selectively kills CXCR4-High expressing AML patient cells in vitro and potently blocks dissemination in vivo","volume":"15","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500767X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500767X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:34:03Z","timestamp":1778546043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500767X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":64,"alternative-id":["S075333222500767X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118573","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118573"}}